Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Awareness, trial, and current use of electronic cigarettes in 10 countries: Findings from the ITC project.
The Role of DCT in HPV16 Infection of HaCaTs.
Long-term outcome of sirolimus rescue in kidney-pancreas transplantation.
Nutrition Assessment
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
Vintafolide: a novel targeted agent for epithelial ovarian cancer. Future Oncol. 2014 Mar; 10(4):541-8.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Clinical Trials as Topic
Drug Evaluation, Preclinical
Female
Folic Acid
Humans
Molecular Targeted Therapy
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Treatment Outcome
Vinca Alkaloids
authors with profiles
Whitney S Graybill